Important Appointment at Janssen Türkiye

Important Appointment at Janssen Turkey Berkin Gökbudak has been appointed as Oncology – Hematology Business Unit Leader at Janssen Turkey, the pharmaceuticals division of Johnson & Johnson. Janssen Turkey, which has operated in Turkey for 22 years drawing on a 135-year scientific legacy, innovative perspective and global vision with a patient-centric approach, has brought Berkin Gökbudak into its leadership team as Oncology – Hematology Business Unit Leader. Berkin Gökbudak, who assumed his position as Oncology – Hematolology Business Unit Leader at Janssen Turkey as of September 2021, where the company builds strong partnerships with public, academic and healthcare professionals for public health, completed his undergraduate education in Industrial Engineering at Sabancı University. Gökbudak subsequently earned his master's degree in Marketing Communications Management at Galatasaray University. Before joining Johnson & Johnson, he held positions in Business Analytics, Product Manager, Global Product Manager, Sales Effectiveness and Customer Relations at Bayer and Alliance Healthcare. Undertaking responsibilities across different therapeutic areas and gaining experience in brand launches, sales and marketing, Berkin Gökbudak most recently served as Women's Health Business Unit Leader for Turkey and Iran regions at Bayer.